Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial

Puntos clave

• Outcomes for first-line treatment improve with nutritional risk screening in metastatic esophagogastric adenocarcinoma.
• Survival rates were significantly higher in patients who underwent nutritional risk assessment, enhancing treatment success.
• Secondary analysis of data from the AIO-MATEO trial showcases the importance of nutritional screening.
• Strengthens the case for incorporating nutritional assessments into cancer treatment protocols for better patient outcomes.